ProMIS Neurosciences Files Proxy Materials

Ticker: PMN · Form: DEFA14A · Filed: 2026-04-09T16:02:22-04:00

Sentiment: neutral

Topics: proxy-filing, shareholder-communication, regulatory-filing

Related Tickers: PMN

TL;DR

PMN filed proxy docs, shareholder vote incoming.

AI Summary

ProMIS Neurosciences Inc. filed a DEFA14A on April 9, 2026, related to additional definitive proxy soliciting materials. The filing includes various documents and graphics, with the complete submission text file being 376,286 bytes. The company's mailing and business address is in Toronto, Canada.

Why It Matters

This filing indicates ProMIS Neurosciences is engaging in proxy solicitations, which are crucial for shareholder voting on important company matters.

Risk Assessment

Risk Level: low — This filing is a standard proxy statement and does not contain new financial or operational information that would inherently increase risk.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of a DEFA14A filing?

A DEFA14A filing is used for additional definitive proxy soliciting materials and Rule 14(a)(12) material, typically used to communicate with shareholders before a meeting.

When was this DEFA14A filing submitted?

The filing date for this DEFA14A was April 9, 2026.

What is the CIK number for ProMIS Neurosciences Inc.?

The CIK number for ProMIS Neurosciences Inc. is 0001374339.

Where is ProMIS Neurosciences Inc. located?

ProMIS Neurosciences Inc.'s mailing and business address is SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2.

What is the size of the complete submission text file for this filing?

The complete submission text file for this filing is 376,286 bytes.

From the Filing

EDGAR Filing Documents for 0001104659-26-041485 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: SEC Accession No. 0001104659-26-041485 Filing Date 2026-04-09 Accepted 2026-04-09 16:02:22 Documents 3 Document Format Files Seq Description Document Type Size 1 DEFA14A pmn-20260409xdefa14a.htm DEFA14A 12582 2 GRAPHIC pmn-20260409xdefa14a_bg001.jpg GRAPHIC 148911 3 GRAPHIC pmn-20260409xdefa14a_bg002.jpg GRAPHIC 119177 Complete submission text file 0001104659-26-041485.txt 376286 Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898 ProMIS Neurosciences Inc. (Filer) CIK : 0001374339 (see all company filings) EIN. : 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231 Type: DEFA14A | Act: 34 | File No.: 001-41429 | Film No.: 26851534 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

View on Read The Filing